Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Aug 26;3(4):147–157. doi: 10.4021/wjon551w

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright 2012, Wirk et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Kaplan-Meier overall survival (OS) and progression-free survival (PFS) curves for the different groups of patients. P values are displayed within the figure for each comparison. Group 1: Patients who had more myelomatous bone disease detected on WBCT than CSS. Group 2: Patients without any differences between CSS and WBCT in the detection of myelomatous bone diseaseGroup 3: Patients without any myelomatous bone disease detected by either modality. Group 4: Patients with myelomatous bone lesions detected by WBCT but not by CSS.Group 5: patients in groups 3 and 4 together.